Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
The scheme is subject to statutory and regulatory approvals as may be necessary.
She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy
Dr. Pedrocchi is currently an Independent Strategic Advisor and Non-Executive Director to private and public healthcare companies.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Subscribe To Our Newsletter & Stay Updated
